Integration of Clinical-grade Optical Genome Mapping for Baseline Diagnostic Profiling of Hematologic Malignancies

Watch a comprehensive seminar presentation where Dr. Rashmi Kanagal-Shamanna, a distinguished triple board-certified Molecular Genetic Pathologist and Hematopathologist, discusses the integration of Clinical-grade Optical Genome Mapping for baseline diagnostic profiling of hematologic malignancies. Learn from her extensive expertise as a tenured Associate Professor at The University of Texas MD Anderson Cancer Center, where she serves as Co-Director of the Bone Marrow Laboratory and Director of the Clinical Molecular Diagnostic Laboratory. Gain insights from her research focusing on novel tools for molecular profiling of hematological malignancies, backed by over 250 peer-reviewed publications. Discover the latest developments in genomic assays and clinical reporting from a leading expert who contributed to the 2022 World Health Organization Classification of Hematolymphoid Tumors and whose work led to the recognition of myeloid neoplasms with isochromosome (17q) as a provisional entity in the International Consensus Classification system.